Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial

Sorrento Therapeutics (SRNE) SEC Filings & 10K Form

$0.0002
-0.01 (-98.33%)
(As of 05/17/2024 08:55 PM ET)

Recent Sorrento Therapeutics SEC Filings

DateFilerForm TypeView
11/07/2023
3:34 PM
Sorrento Therapeutics (Filer)
Sorrento Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/03/2023
4:31 PM
Sorrento Therapeutics (Filer)
Sorrento Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/27/2023
3:15 PM
Sorrento Therapeutics (Filer)
Sorrento Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/05/2023
4:16 PM
Celularity Inc (Issuer)
Celularity Inc (Issuer)
Sorrento Therapeutics (Reporting)
Sorrento Therapeutics, Inc. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/05/2023
4:22 PM
Celularity Inc (Subject)
Celularity Inc (Subject)
Sorrento Therapeutics (Filed by)
Sorrento Therapeutics, Inc. (Filed by)
Form SC 13G/A
10/05/2023
4:26 PM
Sorrento Therapeutics (Filer)
Sorrento Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2023
3:49 PM
Scilex Holding Co (Subject)
Scilex Holding Co (Subject)
Scilex Holding Co (Subject)
Scilex Holding Co (Subject)
Scilex Holding Co (Subject)
Sorrento Therapeutics (Filed by)
Sorrento Therapeutics, Inc. (Filed by)
Form SC 13D/A
09/26/2023
3:54 PM
Sorrento Therapeutics (Filer)
Sorrento Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2023
3:27 PM
Scilex Holding Co (Issuer)
Scilex Holding Co (Issuer)
Scilex Holding Co (Issuer)
Scilex Holding Co (Issuer)
Scilex Holding Co (Issuer)
Sorrento Therapeutics (Reporting)
Sorrento Therapeutics, Inc. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2023
8:51 PM
Sorrento Therapeutics (Filer)
Sorrento Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/28/2023
4:25 PM
Sorrento Therapeutics (Filer)
Sorrento Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/21/2023
10:20 AM
Sorrento Therapeutics (Filer)
Sorrento Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2023
7:59 PM
Scilex Holding Co (Subject)
Scilex Holding Co (Subject)
Scilex Holding Co (Subject)
Scilex Holding Co (Subject)
Scilex Holding Co (Subject)
Sorrento Therapeutics (Filed by)
Sorrento Therapeutics, Inc. (Filed by)
Form SC 13D/A
08/01/2023
5:01 AM
Sorrento Therapeutics (Filer)
Sorrento Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/18/2023
4:23 PM
Sorrento Therapeutics (Filer)
Sorrento Therapeutics, Inc. (Filer)
Form POS AM
07/13/2023
5:26 AM
Sorrento Therapeutics (Filer)
Sorrento Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/07/2023
8:49 PM
Sorrento Therapeutics (Filer)
Sorrento Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2023
4:24 PM
Sorrento Therapeutics (Filer)
Sorrento Therapeutics, Inc. (Filer)
Form POS AM
06/15/2023
8:41 AM
Sorrento Therapeutics (Filer)
Sorrento Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:SRNE) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners